Search research articles
Contact Us
Filters
Showing results (221-230 of 516) with videos related to
Page
of 52
Sort By:
Blood
|
October 24, 2002
Prognostic value of angiogenesis in solitary bone plasmacytoma
Shaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 14, 2006
The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma
Klaus Podar, Giovanni Tonon, Martin Sattler, et al.
Contemporary Clinical Trials Communications
|
August 5, 2022
A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology
Rahma Warsame, Joselle Cook, Briant Fruth, et al.
Blood
|
May 25, 2010
Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications
Giada Bianchi, Robert A Kyle, Colin L Colby, et al.
Haematologica
|
July 24, 2025
Proteomic shifts post plasma cell therapy in AL amyloid plaques and potential implications for light chain directed anti-fibril monoclonal antibodies
Matthew J Rees, Surendra Dasari, Ellen D McPhail, et al.
Blood Cancer Journal
|
December 6, 2023
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma
Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, et al.
British Journal of Haematology
|
June 2, 2020
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic
Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2013
Reply to S. Girnius et al
Giovanni Palladini, Angela Dispenzieri, Morie Gertz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 12, 2013
Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratification
Luciano J Costa, Elizabeth J Nista, Francis K Buadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics
Liewei Wang, Shaji Kumar, Brooke L Fridley, et al.
Page
of 52
Search research articles
Search
Showing results (221-230 of 516) with videos related to
Sort By:
Page
of 52
Blood
|
October 24, 2002
Prognostic value of angiogenesis in solitary bone plasmacytoma
Shaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 14, 2006
The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma
Klaus Podar, Giovanni Tonon, Martin Sattler, et al.
Contemporary Clinical Trials Communications
|
August 5, 2022
A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology
Rahma Warsame, Joselle Cook, Briant Fruth, et al.
Blood
|
May 25, 2010
Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications
Giada Bianchi, Robert A Kyle, Colin L Colby, et al.
Haematologica
|
July 24, 2025
Proteomic shifts post plasma cell therapy in AL amyloid plaques and potential implications for light chain directed anti-fibril monoclonal antibodies
Matthew J Rees, Surendra Dasari, Ellen D McPhail, et al.
Blood Cancer Journal
|
December 6, 2023
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma
Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, et al.
British Journal of Haematology
|
June 2, 2020
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic
Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2013
Reply to S. Girnius et al
Giovanni Palladini, Angela Dispenzieri, Morie Gertz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 12, 2013
Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratification
Luciano J Costa, Elizabeth J Nista, Francis K Buadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics
Liewei Wang, Shaji Kumar, Brooke L Fridley, et al.
Page
of 52